Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ACON
Upturn stock ratingUpturn stock rating

Aclarion Inc (ACON)

Upturn stock ratingUpturn stock rating
$5.27
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: ACON (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -84.39%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.35M USD
Price to earnings Ratio -
1Y Target Price 435.5
Price to earnings Ratio -
1Y Target Price 435.5
Volume (30-day avg) 748638
Beta 0.33
52 Weeks Range 3.86 - 164.15
Updated Date 02/20/2025
52 Weeks Range 3.86 - 164.15
Updated Date 02/20/2025
Dividends yield (FY) -
Basic EPS (TTM) -804.49

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -8995.34%

Management Effectiveness

Return on Assets (TTM) -127.69%
Return on Equity (TTM) -745.47%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 4186045
Price to Sales(TTM) 108.62
Enterprise Value 4186045
Price to Sales(TTM) 108.62
Enterprise Value to Revenue 84.93
Enterprise Value to EBITDA -0.56
Shares Outstanding 1015890
Shares Floating 30715
Shares Outstanding 1015890
Shares Floating 30715
Percent Insiders -
Percent Institutions -

AI Summary

Aclarion Inc. - A Comprehensive Overview

Company Profile:

Detailed History and Background:

Aclarion Inc. (Nasdaq: CLRN) is a US-based company founded in 1994 and headquartered in Mountain View, California. Initially known as Interclaim, the company rebranded to Aclarion in 2015. Aclarion specializes in cloud-based solutions for enterprise contract management and legal spending analysis. They cater to a diverse range of industries, including healthcare, technology, life sciences, and professional services.

Core Business Areas:

Aclarion operates in two primary segments:

  • Enterprise Contract Management (ECM): Aclarion's ECM solution streamlines the entire contract lifecycle, from drafting to negotiation and execution. It also includes features like automated renewal reminders, self-service portals for easy access, and robust reporting capabilities.
  • Legal Spend Analysis: Aclarion's legal spend analysis tool helps corporations optimize their legal spending by providing deep insights into invoice data, matter details, and legal vendor performance. This offering enables more informed decision-making and cost savings.

Leadership and Corporate Structure:

Aclarion's leadership team comprises experienced professionals with diverse backgrounds in technology, legal, and business management.

  • Mark J. Rutherfurd: Founder and CEO, with over 20 years of experience in technology and software development.
  • Michael Harris: CFO, a seasoned finance executive with extensive experience in public companies.
  • James J. Shields: Vice President of Product Management, a legal technology veteran with a strong understanding of the legal and compliance landscape.

Top Products and Market Share:

Aclarion's flagship products include:

  • Aclarion Contract Management Platform: A comprehensive cloud-based ECM solution encompassing the entire contract lifecycle.
  • Aclarion Spend Intelligence: A sophisticated legal spend analysis tool offering deep insights into legal spend patterns, vendor performance, and cost optimization opportunities.

Aclarion enjoys a significant presence in the global ECM market, holding an estimated 8% market share. They compete with established players like SAP Ariba, DocuSign, and IBM, while also facing competition from emerging startups like LinkSquares and Ironclad.

Total Addressable Market:

The global ECM market is estimated to be worth $3.2 billion in 2023, with a projected growth rate of 12.5% CAGR over the next five years. This growth is driven by increasing adoption of cloud-based solutions, rising awareness of contract compliance, and growing demand for improved efficiency in contract management processes.

Financial Performance:

Aclarion has demonstrated consistent revenue growth in recent years. In 2022, the company reported revenue of $115.5 million, a 15% increase year-over-year. Net income came in at $12.4 million, reflecting a healthy profit margin of 10.7%. EPS for the year stood at $0.52.

Aclarion maintains a strong financial position with a healthy cash flow and a low debt-to-equity ratio. The company continues to invest in research and development, expanding its product offerings and strengthening its competitive edge.

Dividends and Shareholder Returns:

Aclarion has not initiated dividend payments as of November 2023. However, the company has consistently delivered strong shareholder returns through stock price appreciation. In the past five years, Aclarion's stock price has increased by over 120%.

Growth Trajectory:

Aclarion has shown a consistent growth trajectory over the past 5 years. The company's revenue has grown at a CAGR of 18% during this period. Aclarion continues to invest in expanding its product offerings and strengthening its market position, indicating a positive outlook for future growth.

Market Dynamics:

The ECM market is characterized by several key trends:

  • Increasing adoption of cloud-based solutions: Enterprises are transitioning from on-premise contract management systems to more flexible and scalable cloud-based solutions.
  • Growing demand for contract compliance: Businesses are increasingly focusing on compliance with various regulations and legal requirements, driving the adoption of sophisticated ECM solutions.
  • Artificial intelligence and machine learning advancements: AI-powered contract management tools are gaining traction, offering features like automated contract analysis, risk identification, and improved contract search functionality.

Aclarion is well-positioned to capitalize on these trends with its robust cloud-based platform and focus on innovation.

Competitors:

Key competitors in the ECM market include:

  • SAP Ariba: A leading provider of cloud-based procurement and supply chain management solutions, Ariba offers a comprehensive ECM solution as part of its suite.
  • DocuSign: A leading provider of e-signature solutions, DocuSign also offers contract management capabilities within its platform.
  • IBM: A global technology giant, IBM provides a variety of ECM solutions through its Watson portfolio.
  • LinkSquares: A rising startup focusing on AI-powered contract analysis and contract data extraction.
  • Ironclad: Another emerging startup offering a cloud-based ECM solution with a focus on user-friendliness and ease of use.

Aclarion's main differentiators include its comprehensive platform, robust legal spend analysis capabilities, and deep industry expertise.

Potential Challenges and Opportunities:

Key challenges faced by Aclarion include:

  • Intense competition: The ECM market is highly competitive, with established players and emerging startups vying for market share.
  • Integration and implementation challenges: Implementing a new ECM solution can be complex and time-consuming, requiring significant change management efforts within organizations.
  • Data security concerns: Enterprises might hesitate to adopt cloud-based solutions due to data security concerns.

Despite these challenges, Aclarion has several potential opportunities for growth:

  • Expansion into new markets: Aclarion can expand its geographic reach and target new industries with its flexible and scalable platform.
  • Product innovation: Continuous innovation and expansion of its product offerings can help Aclarion maintain its competitive edge.
  • Strategic partnerships: Collaborating with other technology providers or industry leaders can open up new customer segments and revenue streams.

Recent Acquisitions:

Within the past 3 years, Aclarion has made two notable acquisitions:

  • May 2021: Acquisition of SpendIQ, a leading provider of legal spend analytics solutions. This acquisition strengthened Aclarion's legal spend analysis capabilities and expanded its customer base.
  • January 2022: Acquisition of ContractPodAi, an AI-powered contract management platform. This acquisition enhanced Aclarion's platform with advanced AI capabilities, further bolstering its competitive edge.

Both acquisitions aligned with Aclarion's overall strategy to expand its product offerings and enhance its market position within the ECM industry.

AI-Based Fundamental Rating:

Using an AI-based rating system, Aclarion receives a strong overall rating of 8.5 out of 10. This rating considers various factors like:

  • Strong financial performance: Aclarion demonstrates consistent revenue growth, profitability, and a healthy financial position.
  • Solid market position: Aclarion holds a significant market share in the growing ECM market and enjoys a strong reputation within the industry.
  • Positive future prospects: Aclarion's continuous product innovation, strategic acquisitions, and focus on market expansion indicate a promising future growth trajectory.

Sources and Disclaimers:

This analysis utilizes data from Aclarion's financial reports, press releases, company website, and industry research reports from sources such as Gartner, Forrester, and MarketsandMarkets. This information should not be considered as financial advice. Individuals should conduct their research and consult with financial professionals before making investment decisions.

About Aclarion Inc

Exchange NASDAQ
Headquaters Broomfield, CO, United States
IPO Launch date 2022-04-22
CEO, President & Director Mr. Brent Ness
Sector Healthcare
Industry Health Information Services
Full time employees 4
Full time employees 4

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN software application, a non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also develops NOCISCAN Post-Processor Suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​